Risk stratification in nonmuscle-invasive bladder cancer (CME)
By risk-stratifying nonmuscle-invasive bladder cancers, urologists can characterize pathologic
subtypes and develop individualized treatment and surveillance strategies.(CME)
Archive for October, 2008
Adjuvant chemotherapy ‘essential’ to bladder cancer treatment
Adjuvant chemotherapy is an essential part of the treatment protocol for lymph node-positive bladder
cancer.
Patience required when evaluating radiofrequency ablation
Evaluating the efficacy of radiofrequency ablation of renal cortical tumors requires a degree of
patience because histologic changes and cell death in and near lesions targeted by the treatment may continue to
evolve for a year or even longer.